The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by O'quinn Shari L since 2016.
The trader's CIK number is 1605343.
At the time of the last reporting, O'quinn Shari L was the VP Clinical/Regulatory Affairs of Endologix Inc /de/. (stock ticker symbol ELGX).
Also see all insider trading activities at Endologix Inc /de/.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | TRIV | 0 | $0 | 0 | $0 | 51,238 | $62,254 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | ELGX | 0 | $0 | 4,000 | $0 | 0 | $0 |
1. Trivascular Technologies, Inc. (TRIV)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-02-03 | TRIV | Option Ex | 51,238 | 1.22 | 62,254 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-02-29 | ELGX | Sale | 4,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by O'quinn Shari L (VP Clinical/Regulatory Affairs of Endologix Inc /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.